Quest Diagnostics Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Quest Diagnostics (DGX) PT Lowered to $121 at Credit Suisse
October 24, 2018 8:47 AM EDTCredit Suisse analyst A.J. Rice lowered the price target on Quest Diagnostics (NYSE: DGX) to $121.00 (from $128.00) while maintaining an Outperform rating following results.
Rice said Long-term Tailwinds Still in Play, Despite a Short-term Speed Bump.
... MoreQuest Diagnostics (DGX) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 EPS/Reveunes Outlook
October 23, 2018 6:48 AM EDTQuest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.68, in-line with the analyst estimate of $1.68. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.95 billion.
"We grew revenues and continued to deliver strong earnings growth in the third quarter," said... More



